key: cord-0976997-88qt2f0u
authors: Mendizabal, Manuel; Pages, Josefina; Piñero, Federico; Thompson, Marcos; Silva, Marcelo O
title: Liver Transplant Outcomes during the COVID-19 pandemic
date: 2021-12-23
journal: Ann Hepatol
DOI: 10.1016/j.aohep.2021.100656
sha: 773da002a8f3dd8a5dd709f9fa9ec8d187367a39
doc_id: 976997
cord_uid: 88qt2f0u

nan

The COVID-19 pandemic has pushed the healthcare system to its limits worldwide.

Consequently, many resources were mobilized to guarantee care for patients with SARS-CoV-2 infection, relegating many other healthcare programs. Argentina remains one of the most affected countries by the pandemic, with over 116,000 deaths and a dramatic economic situation. In this scenario, management of other pathologies has been reduced, including solid organ transplantation. Indeed, the number of transplants has substantially decreased across the world (1). During the first year of the pandemic, Argentina faced a significant reduction in liver donation and transplantation rates, of 59% and 55%, respectively (2) . However, the impact of all the restrictive healthcare policies on liver transplant (LT) outcomes has scantly been described. Thus, we aimed to evaluate the severity of liver disease at the time of LT and analyze the outcomes of those patients transplanted during the COVID-19 pandemic. We conducted a retrospective review of the LT database at the Austral University Hospital in Buenos Aires, 

Impact of COVID-19 in solid organ transplant recipients

Impact of COVID-19 pandemic in liver transplantation in Argentina